HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin.

AbstractBACKGROUND AND AIMS:
Hepatic stellate cells (HSC) are known to synthesise excess matrix that characterises liver fibrosis and cirrhosis. Activated HSC express the matrix-degrading matrix metalloproteinase enzymes (MMPs) and their tissue inhibitors (TIMPs). During spontaneous recovery from experimental liver fibrosis, the expression of TIMP-1 declines and hepatic collagenolytic activity increases. This is accompanied by HSC apoptosis. In this study, we examine a potential mechanism whereby MMP activity might induce HSC apoptosis by cleaving N-cadherin at the cell surface.
RESULTS:
N-cadherin expression was upregulated in human HSC during activation in culture. Addition of function-blocking antibodies or a peptide targeting the extracellular domain of N-cadherin, to cultured HSC, promoted apoptosis. During apoptosis, there was cleavage of N-cadherin into 20-100 kDa fragments. MMP-2 became activated early during HSC apoptosis and directly cleaved N-cadherin in vitro. Addition of activated MMP-2 to HSCs in culture resulted in enhanced apoptosis and loss of N-cadherin.
CONCLUSIONS:
Together, these studies identify a role for both N-cadherin and MMP-2 in mediating HSC apoptosis, where N-cadherin works to provide a cell survival stimulus and MMP-2 promotes HSC apoptosis concomitant with N-cadherin degradation.
AuthorsStephen N Hartland, Frank Murphy, Rebecca L Aucott, Armand Abergel, Xiaoying Zhou, Julian Waung, Nishit Patel, Catherine Bradshaw, Jane Collins, Derek Mann, R Christopher Benyon, John P Iredale
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 29 Issue 7 Pg. 966-78 (Aug 2009) ISSN: 1478-3231 [Electronic] United States
PMID19580633 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • CDH2 protein, human
  • Cadherins
  • Cdh2 protein, mouse
  • Recombinant Proteins
  • Gliotoxin
  • Cycloheximide
  • Carbon Tetrachloride
  • Caspase 3
  • MMP2 protein, human
  • Matrix Metalloproteinase 2
  • Mmp2 protein, mouse
Topics
  • Animals
  • Antigens, CD (metabolism)
  • Apoptosis (drug effects)
  • Cadherins (metabolism)
  • Carbon Tetrachloride
  • Caspase 3 (metabolism)
  • Cells, Cultured
  • Cycloheximide (pharmacology)
  • Enzyme Activation
  • Gliotoxin (pharmacology)
  • Hepatic Stellate Cells (drug effects, enzymology, pathology)
  • Humans
  • Liver (drug effects, enzymology, pathology)
  • Liver Cirrhosis, Experimental (chemically induced, enzymology, pathology)
  • Matrix Metalloproteinase 2 (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Rats
  • Recombinant Proteins (metabolism)
  • Signal Transduction
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: